Neogen Corporation Revenue, Net (Deprecated 2018-01-31)
Neogen Corporation (NEOG) reported Revenue, Net (Deprecated 2018-01-31) of $95.89 million for the 3-month period ending 2018-02-28, per its 10-Q filed 2018-03-29.
Discontinued › Income Statement
us-gaap:SalesRevenueNet · last filed 2018-03-29
- Neogen Corporation revenue, net (deprecated 2018-01-31) for the quarter ending 2018-02-28 was $95.89M, a 8.49% increase year-over-year.
- Neogen Corporation revenue, net (deprecated 2018-01-31) for the quarter ending 2017-11-30 was $101.82M, a 12.24% increase year-over-year.
- Neogen Corporation revenue, net (deprecated 2018-01-31) for the quarter ending 2017-08-31 was $95.26M, a 13.88% increase year-over-year.
- Neogen Corporation revenue, net (deprecated 2018-01-31) for the quarter ending 2017-05-31 was $98.85M, a 9.73% increase year-over-year.
- Neogen Corporation revenue, net (deprecated 2018-01-31) for fiscal 2017 was $361.59M, a 12.55% increase from fiscal 2016.
- Neogen Corporation revenue, net (deprecated 2018-01-31) for fiscal 2016 was $321.27M, a 13.50% increase from fiscal 2015.
- Neogen Corporation revenue, net (deprecated 2018-01-31) for fiscal 2015 was $283.07M, a 14.42% increase from fiscal 2014.
- Neogen Corporation revenue, net (deprecated 2018-01-31) for fiscal 2014 was $247.41M, a 19.22% increase from fiscal 2013.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-02-28 | $95.89M 10-Q · filed 2018-03-29 | $197.71M derived: sum of 2 quarters · filed 2018-03-29 | $292.96M 10-Q · filed 2018-03-29 | $391.81M derived: sum of 4 quarters · filed 2018-03-29 |
| 2017-11-30 | $101.82M 10-Q · filed 2018-01-05 | $197.07M 10-Q · filed 2018-01-05 | $295.92M derived: sum of 3 quarters · filed 2018-01-05 | $384.31M derived: sum of 4 quarters · filed 2018-01-05 |
| 2017-08-31 | $95.26M 10-Q · filed 2017-09-29 | $194.10M derived: sum of 2 quarters · filed 2017-09-29 | $282.49M derived: sum of 3 quarters · filed 2017-09-29 | $373.20M derived: sum of 4 quarters · filed 2018-01-05 |
| 2017-05-31 | $98.85M 10-K · filed 2017-07-28 | $187.23M derived: sum of 2 quarters · filed 2017-07-28 | $277.95M derived: sum of 3 quarters · filed 2018-01-05 | $361.59M 10-K · filed 2017-07-28 |
| 2017-02-28 | $88.39M 10-Q · filed 2018-03-29 | $179.10M derived: sum of 2 quarters · filed 2018-01-05 | $262.75M 10-Q · filed 2018-03-29 | $352.83M derived: sum of 4 quarters · filed 2018-01-05 |
| 2016-11-30 | $90.72M 10-Q · filed 2018-01-05 | $174.36M 10-Q · filed 2018-01-05 | $264.44M derived: sum of 3 quarters · filed 2018-01-05 | $341.17M derived: sum of 4 quarters · filed 2018-01-05 |
| 2016-08-31 | $83.64M 10-Q · filed 2017-09-29 | $173.72M derived: sum of 2 quarters · filed 2017-09-29 | $250.45M derived: sum of 3 quarters · filed 2017-09-29 | $330.06M derived: sum of 4 quarters · filed 2017-09-29 |
| 2016-05-31 | $90.08M 10-K · filed 2017-07-28 | $166.81M derived: sum of 2 quarters · filed 2017-07-28 | $246.41M derived: sum of 3 quarters · filed 2017-07-28 | $321.27M 10-K · filed 2017-07-28 |
| 2016-02-29 | $76.72M 10-K · filed 2017-07-28 | $156.34M derived: sum of 2 quarters · filed 2017-07-28 | $231.20M 10-Q · filed 2017-03-31 | $309.81M derived: sum of 4 quarters · filed 2017-07-28 |
| 2015-11-30 | $79.61M 10-K · filed 2017-07-28 | $154.47M 10-Q · filed 2016-12-29 | $233.08M derived: sum of 3 quarters · filed 2017-07-28 | $301.49M derived: sum of 4 quarters · filed 2017-07-28 |
| 2015-08-31 | $74.86M 10-Q · filed 2016-09-30 | $153.47M derived: sum of 2 quarters · filed 2017-07-28 | $221.88M derived: sum of 3 quarters · filed 2017-07-28 | $290.33M derived: sum of 4 quarters · filed 2017-07-28 |
| 2015-05-31 | $78.61M 10-K · filed 2016-07-29 | $147.02M derived: sum of 2 quarters · filed 2016-07-29 | $215.47M derived: sum of 3 quarters · filed 2016-07-29 | $283.07M 10-K · filed 2017-07-28 |
| 2015-02-28 | $68.41M 10-Q · filed 2016-03-31 | $136.86M derived: sum of 2 quarters · filed 2016-07-29 | $204.46M 10-Q · filed 2016-03-31 | $271.73M derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-11-30 | $68.45M 10-K · filed 2016-07-29 | $136.05M 10-Q · filed 2016-01-08 | $203.32M derived: sum of 3 quarters · filed 2016-07-29 | $265.31M derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-08-31 | $67.60M 10-K · filed 2016-07-29 | $134.86M derived: sum of 2 quarters · filed 2016-07-29 | $196.86M derived: sum of 3 quarters · filed 2016-07-29 | $256.46M derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-05-31 | $67.26M 10-K · filed 2015-07-30 | $129.26M derived: sum of 2 quarters · filed 2015-07-30 | $188.86M derived: sum of 3 quarters · filed 2015-07-30 | $247.41M 10-K · filed 2016-07-29 |
| 2014-02-28 | $62.00M 10-K · filed 2015-07-30 | $121.59M derived: sum of 2 quarters · filed 2015-07-30 | $180.14M 10-Q · filed 2015-04-01 | $236.15M derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-11-30 | $59.60M 10-K · filed 2015-07-30 | $118.15M 10-Q · filed 2014-12-30 | $174.15M derived: sum of 3 quarters · filed 2015-07-30 | $225.21M derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-08-31 | $58.55M 10-K · filed 2015-07-30 | $114.56M derived: sum of 2 quarters · filed 2015-07-30 | $165.61M derived: sum of 3 quarters · filed 2015-07-30 | $216.35M derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-05-31 | $56.01M 10-K · filed 2014-07-30 | $107.06M derived: sum of 2 quarters · filed 2014-07-30 | $157.80M derived: sum of 3 quarters · filed 2014-07-30 | $207.53M 10-K · filed 2015-07-30 |
| 2013-02-28 | $51.05M 10-K · filed 2014-07-30 | $101.79M derived: sum of 2 quarters · filed 2014-07-30 | $151.52M 10-Q · filed 2014-04-04 | $200.07M derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-11-30 | $50.74M 10-K · filed 2014-07-30 | $100.47M 10-Q · filed 2014-01-09 | $149.01M derived: sum of 3 quarters · filed 2014-07-30 | $193.92M derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-08-31 | $49.73M 10-K · filed 2014-07-30 | $98.28M derived: sum of 2 quarters · filed 2014-07-30 | $143.19M derived: sum of 3 quarters · filed 2014-07-30 | $188.08M derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-05-31 | $48.55M 10-K · filed 2013-07-30 | $93.46M derived: sum of 2 quarters · filed 2013-07-30 | $138.35M derived: sum of 3 quarters · filed 2013-07-30 | $184.05M 10-K · filed 2014-07-30 |
| 2012-02-29 | $44.91M 10-K · filed 2013-07-30 | $89.80M derived: sum of 2 quarters · filed 2013-07-30 | $135.50M 10-Q · filed 2013-03-28 | $179.09M derived: sum of 4 quarters · filed 2013-07-30 |
| 2011-11-30 | $44.89M 10-K · filed 2013-07-30 | $90.59M 10-Q · filed 2012-12-28 | $134.18M derived: sum of 3 quarters · filed 2013-07-30 | $176.42M derived: sum of 4 quarters · filed 2013-07-30 |
| 2011-08-31 | $45.70M 10-K · filed 2013-07-30 | $89.29M derived: sum of 2 quarters · filed 2013-07-30 | $131.53M derived: sum of 3 quarters · filed 2013-07-30 | $175.46M derived: sum of 4 quarters · filed 2013-07-30 |
| 2011-05-31 | $43.59M 10-K · filed 2012-07-30 | $85.83M derived: sum of 2 quarters · filed 2012-07-30 | $129.76M derived: sum of 3 quarters · filed 2012-07-30 | $172.68M 10-K · filed 2013-07-30 |
| 2011-02-28 | $42.23M 10-K · filed 2012-07-30 | $86.17M derived: sum of 2 quarters · filed 2012-07-30 | $129.09M 10-Q · filed 2012-03-30 | |
| 2010-11-30 | $43.93M 10-K · filed 2012-07-30 | $86.85M 10-Q · filed 2011-12-30 | ||
| 2010-08-31 | $42.92M 10-K · filed 2012-07-30 | |||
| 2010-05-31 | $140.51M 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |